Removal of Methotrexate by Peritoneal Dialysis and Hemodialysis in a Single Patient with End-Stage Renal Disease
暂无分享,去创建一个
C. Diskin | T. Stokes | L. Dansby | L. Radcliff | T. Carter
[1] J. Heaf,et al. A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] A. Craft,et al. High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma , 2004, Cancer.
[3] G. Deray,et al. Severe methotrexate intoxication in a haemodialysis patient treated for rheumatoid arthritis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[4] S. Wall,et al. Effective clearance of methotrexate using high-flux hemodialysis membranes. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] G. Houin,et al. Protein binding of methotrexate to human albumin and serum. A first derivative spectroscopic analysis. , 1991, Arzneimittel-Forschung.
[6] P. Piedbois,et al. [Effectiveness of hemodialysis in a case of acute methotrexate poisoning]. , 1990, Presse medicale.
[7] J. Kremer,et al. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. , 1986, Arthritis and rheumatism.
[8] W. Bleyer,et al. Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis. , 1978, Archives of internal medicine.
[9] P. Harden,et al. Methotrexate removal during haemodialysis in a patient with advanced laryngeal carcinoma , 1996, Cancer Chemotherapy and Pharmacology.